For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Eltrombopag | Single arm study. Dose Escalation. Eltrombopag: Oral eltrombopag 150mg/day by mouth starting on Day 1 with dose modification over 12 weeks to a maximum of 300mg/day determined by platelet count | 2 | None | 3 | 13 | 13 | 13 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| aches/pains | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| arrhythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| purpura | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| bronzing of the skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| bruising | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| chest pain | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| chills | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| confusion | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| cramps | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| decreased lymphocyte count | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| decreased neutrophil count | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| thrombocytopenia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dysuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| ecchymosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| edema | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Alkaline phosphatase increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| elevated ALT | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| elevated AST | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| elevated bilirubin | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| elevated creatinine | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| erythema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| gum hypertrophy | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| gum lesions | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| facial hair growth | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hot flashes | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hypoalbunemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| jaundice | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| menorrhagia | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| mouth sores | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| nasal congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| otitis externa | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| night sweats | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| opacity | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pallor | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| petechiae | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| port leak | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pyelonephritis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| rectal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| renal insufficiency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| respiratory infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| sciatica | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| scleral icterus | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| spelnomegaly | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| thrush | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| transfusion reaction | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| weight gain | SYSTEMATIC_ASSESSMENT | Investigations | None | View |